Robert L. Van Nostrand BS
Director, Chairman of Audit Committee and Member of Compensation Committee, Achillion Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 22 board members in 3 different organizations across 5 different industries.|
See Board Relationships
Mr. Robert L. Van Nostrand, Bob, BS served as the Chief Financial Officer and Executive Vice President of Aureon Laboratories, Inc. since January 2010. Mr. Van Nostrand has responsibility for all financial aspects of the Aureon Laboratories's activities. He served as the Chief Financial Officer and Executive Vice President of Applied Genetics, Inc. (formerly, AGI Dermatics). Mr. Van Nostrand served as the Chief Compliance Officer and Senior Vice President of OSI Pharmaceuticals ...
300 George StreetPhone: 203-624-7000
New Haven, Connecticut 06511
Board Members Memberships*
Independent Director and Member of Audit Committee
Director and Chairman of Audit Committee
Director, Chairman of Audit Committee and Member of Compensation Committee
Long Island University
University of Pennsylvania - The Wharton School
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Lamberto Andreotti||Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee|
Bristol-Myers Squibb Company
|Jeffrey M. Leiden M.D., Ph.D.||Chairman, Chief Executive Officer and President|
Vertex Pharmaceuticals Incorporated
|Kenneth I. Moch||Chief Executive Officer, President and Director|
|Anders Hedegaard MSc||Chief Executive Officer and President|
Bavarian Nordic A/S
|Daniel J. Abdun-Nabi||Chief Executive Officer, President, Director and Member of Strategic Operations Committee|
Emergent BioSolutions, Inc.
|$860.3K||Compensation as of Fiscal Year 2012.|
Post a JobJobs
- New York, NY | JPMorgan ChasePosted: Dec 06
- Alexandria, VA |Posted: Dec 06
- Detroit, MI | Wayne State UniversityPosted: Nov 26
- New York, NY | AGORAPosted: Nov 25